EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: A hospital-based observational study

Manjula Gudhoor iD, Aneetta Thankam Mathew iD, Akul Madiwalayya Ganachari, Gayathri Baiju, Sushrut Sachchidanand Kulkarni, M S Ganachari

Journal of Oncology Pharmacy Practice · 2024

DOI: 10.1177/10781552231189706 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Oncology Pharmacy Practice, 2024. Verfasst von Manjula Gudhoor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, KLE College of Pharmacy, KLE Academy for Higher Education and Research (KAHER), Belagavi, Karnataka, India. Hauptthemen laut MEDLINE: Quality of Life, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this new era of cancer management, the quality of life (QOL) is given more importance than the quantity of life. QOL evaluation studies are widely used in oncology to assess the patient's performance in different cancer types and treatment modalities.

Objective

To evaluate cancer patients’ QOL after various chemotherapy cycles.

Methods

An observational study was performed on cancer patients receiving chemotherapy in the daycare setting of a South Indian Tertiary Care Hospital for 6 months. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) questionnaire was employed to study the QOL.

Results

Precisely, 102 patients participated in the study, out of which the majority were in the 51 to 60 age group (24%). Female participants (65%) were more. Functional scale domains especially physical ability ( P = 0.004), role ( P = 0.033), and emotional functioning ( P = 0.01) were significantly decreased in patients treated with 4 to 6 chemotherapy cycles. Cognitive ability ( P = 0.043) significantly improved in patients treated with more than 6 chemotherapy cycles. Dyspnea ( P = 0.036) was significantly increased in patients treated with 4 to 6 chemotherapy cycles and decreased significantly with the further addition of chemotherapy cycles.

Conclusion

Dyspnea is a commonly observed symptom among cancer patients and is often neglected by physicians. Chronic dyspnea can negatively impact a patient's functional ability. Cancer symptoms such as dyspnea should also be given priority and need appropriate treatment. Based on the findings, further interventions can be made to improve the functional ability of cancer patients. Also, studies can be conducted to correlate with cancer rehabilitation programs to improve functional ability and complete the entire chemotherapy cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeNeoplasmsHumansFemaleMiddle AgedMaleSurveys and QuestionnairesAgedAdultAntineoplastic AgentsIndiaTertiary Care Centers

Stichwörter der Autor:innen

EORTC QLQ-C30dyspneafunctional abilityquality of liferehabilitation

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice, KLE College of Pharmacy, KLE Academy for Higher Education and Research (KAHER), Belagavi, Karnataka, India.

ORCID-Profile: Manjula Gudhoor, Aneetta Thankam Mathew

Zitieren

APA

Gudhoor, M., Mathew, A. T., Ganachari, A. M., Baiju, G., Kulkarni, S. S., & Ganachari, M. S. (2024). Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: A hospital-based observational study. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231189706

Vancouver

Gudhoor M, Mathew AT, Ganachari AM, Baiju G, Kulkarni SS, Ganachari MS. Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: A hospital-based observational study. Journal of Oncology Pharmacy Practice. 2024. doi:10.1177/10781552231189706

BibTeX
@article{Gudhoor2024,
  author = {Gudhoor, Manjula and Mathew, Aneetta Thankam and Ganachari, Akul Madiwalayya and Baiju, Gayathri and Kulkarni, Sushrut Sachchidanand and Ganachari, M S},
  title = {Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: A hospital-based observational study},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2024},
  doi = {10.1177/10781552231189706}
}
Kostenlos starten →